RxSight, Inc.

RXST

RxSight, Inc.

RXST

Insider Sentiment (TTM):

Last Purchase:2025-01-16Last Sale:2025-03-12Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:36,149,987Shares Outstanding:41,306,110Institutional Ownership Pct.:87.52%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Ophthalmic Goods

COO BLCO WRBY EYE STAA LUCY

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	18	20	30	40	28	17	17	24	33	10	10	9
Short Term Investments	200	208	198	187	201	221	220	209	93	117	122	138
Accounts Receivable Net Current	22	23	24	28	31	30	25	26	22	20	15	13
Inventory Net	35	32	29	25	24	22	22	19	19	17	19	18
Prepaid Expense And Other Assets Current	4	4	3	3	5	5	3	3	3	4	2	2
Assets Current	279	287	284	284	288	294	287	281	169	168	168	180
Property Plant And Equipment Net	13	13	13	13	13	12	12	12	12	11	10	11
Operating Lease Right Of Use Asset	10	10	10	11	11	11	11	11	2	2	3	3
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	1	1	1	1	0	0	0	0	0	0	0	0
Assets	304	312	309	309	313	319	310	305	183	183	182	195
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	7	5	3	3	7	5	5	5	5	4	4	4
Accrued Liabilities And Other Liabilities	19	20	18	16	15	20	17	14	12	15	13	11
Liabilities Current	27	26	22	20	23	26	23	20	18	21	19	17
Liabilities Other Than Longterm Debt Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Long Term Debt	-	-	-	-	-	-	-	-	-	0	0	20
Liabilities	37	36	33	31	34	37	33	30	19	22	20	38
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	944	937	928	920	910	903	893	885	768	755	747	730
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	-0	0	0	1	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-677	-661	-652	-642	-630	-622	-616	-610	-604	-595	-585	-573
Stockholders Equity	267	276	276	278	279	281	277	275	164	160	161	157
Liabilities And Stockholders Equity	304	312	309	309	313	319	310	305	183	183	182	195
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	900	900	900	900	900	900	900	900	900	900	900	900
Common Stock Shares Issued	41	41	41	41	41	40	40	40	37	36	36	35
Shares Outstanding	41	41	41	41	41	40	40	40	37	36	36	35
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-21.39%	-20.94%	-23.45%	-	-	-	-	-	-	-	-	-
2025	2.62%	-14.97%	-46.51%	16.05%	15.92%	10.53%	36.93%	31.06%	14.03%	-26.90%	-13.62%	-35.53%
2024	-6.95%	-4.25%	-29.19%	38.28%	19.03%	23.54%	-7.81%	-32.70%	-36.13%	-14.96%	-50.60%	-51.42%
2023	35.22%	49.61%	73.19%	1.21%	-3.29%	-26.18%	23.78%	69.41%	97.90%	-13.89%	-8.53%	7.55%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	10.20	10.95	12.74	13.93	12.68	11.36	12.67	14.33	9.20	8.06	8.87	10.89
Quick Ratio	8.78	9.58	11.29	12.54	11.45	10.33	11.60	13.20	8.02	7.05	7.77	9.68
Working Capital	251.85M	261.21M	261.59M	263.49M	265.67M	267.95M	264.13M	261.61M	150.23M	147.50M	149.01M	163.88M
Leverage & Debt
Debt to Equity	0.14	0.13	0.12	0.11	0.12	0.13	0.12	0.11	0.12	0.14	0.13	0.24
Interest Coverage TTM	-3,459.13	-2,536.37	-2,393.89	-2,126.60	-1,755.33	-1,755.14	-1,954.00	-172.92	-26.37	-15.14	-11.40	-9.90
Debt Ratio	0.12	0.12	0.11	0.10	0.11	0.12	0.11	0.10	0.11	0.12	0.11	0.19
Efficiency & Turnover
Asset Turnover TTM	0.41	0.43	0.46	0.48	0.60	0.56	0.52	0.46	0.52	0.54	0.45	0.37
Days Sales Outstanding TTM	76.45	72.51	63.60	66.74	64.61	65.64	57.77	61.82	61.77	64.00	57.82	54.96
Receivables Turnover TTM	4.77	5.03	5.74	5.47	5.65	5.56	6.32	5.90	5.91	5.70	6.31	6.64
Per Share Metrics
Diluted EPS TTM	-1.13	-0.95	-0.87	-0.79	-0.66	-0.71	-0.77	-0.96	-1.21	-1.41	-1.54	-1.72
Free Cash Flow Per Share TTM	-0.52	-0.47	-0.54	-0.51	-0.51	-0.58	-0.68	-0.92	-1.06	-1.35	-1.42	-1.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	77.02%	76.60%	74.98%	73.12%	71.87%	70.71%	68.44%	66.26%	63.39%	60.36%	56.84%	52.48%
Operating Profit Margin TTM	-43.42%	-35.84%	-32.01%	-28.92%	-24.85%	-26.34%	-30.46%	-36.78%	-47.14%	-56.23%	-70.80%	-86.07%
Net Profit Margin TTM	-36.59%	-28.96%	-25.15%	-21.93%	-17.90%	-19.62%	-23.93%	-31.93%	-44.01%	-54.57%	-71.87%	-88.72%
Growth Metrics
Net Revenue Growth (1Y)	-14.05%	-3.89%	10.75%	27.68%	46.70%	57.09%	67.51%	71.90%	75.67%	81.77%	70.85%	76.33%
Net Income Growth (1Y)	75.69%	41.85%	16.41%	-12.29%	-40.34%	-43.52%	-44.23%	-38.14%	-28.66%	-27.19%	-25.30%	-14.52%
EPS Growth (1Y)	72.31%	34.96%	13.06%	-17.21%	-45.74%	-49.93%	-50.02%	-44.51%	-38.74%	-41.54%	-42.05%	-31.71%
Valuation Metrics
P/E TTM	-5.46	-10.93	-10.31	-16.42	-38.53	-48.67	-64.08	-62.93	-42.71	-28.58	-18.07	-16.71
P/B TTM	0.95	1.54	1.33	1.91	3.66	4.75	7.09	8.41	11.59	8.66	6.16	6.32
P/S TTM	2.00	3.17	2.59	3.60	6.90	9.55	15.33	20.09	18.80	15.60	12.99	14.83
Market Cap	254.45M	425.66M	368.28M	529.67M	1.02B	1.34B	1.97B	2.31B	1.90B	1.39B	994.62M	993.55M
Enterprise Value	236.12M	404.97M	337.90M	488.56M	994.12M	1.32B	1.95B	2.29B	1.87B	1.38B	984.06M	1.00B
Calculated Values
Free Cash Flow TTM	-21.58M	-19.34M	-22.20M	-20.88M	-20.52M	-22.39M	-27.17M	-35.35M	-39.17M	-46.41M	-50.73M	-57.86M
Net Debt	-18.32M	-20.70M	-30.38M	-41.11M	-28.75M	-17.46M	-17.43M	-25.16M	-33.36M	-10.40M	-10.57M	10.08M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-03-12Sale

Owner: Fountain, Tamara

Title: -

Shares: 7,000

Price/Share: $25.71

Value: $179,970.00

Shares Owned: 24,793

Relationship: Director

Ownership: Direct

2025-01-22Sale

Owner: Maniar, Shweta

Title: -

Shares: 3,519

Price/Share: $30.87

Value: $108,631.53

Shares Owned: 7,383

Relationship: Director

Ownership: Direct

2025-01-16Purchase

Owner: Corley, Jesse Anderson

Title: -

Shares: 1,767

Price/Share: $31.13

Value: $55,006.71

Shares Owned: 3,210

Relationship: Director

Ownership: Indirect

2024-11-29Sale

Owner: Goldshleger, Ilya

Title: See remarks

Shares: 3,105

Price/Share: $46.08

Value: $143,078.40

Shares Owned: 42,246

Relationship: Officer

Ownership: Direct

2024-11-26Sale

Owner: Goldshleger, Ilya

Title: See remarks

Shares: 3,100

Price/Share: $45.88

Value: $142,228.00

Shares Owned: 42,246

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-03-12	Fountain, Tamara	Director	-	Direct	Sale	7,000	25.71	$179,970.00	24,793	4
2025-01-22	Maniar, Shweta	Director	-	Direct	Sale	3,519	30.87	$108,631.53	7,383	4
2025-01-16	Corley, Jesse Anderson	Director	-	Indirect	Purchase	1,767	31.13	$55,006.71	3,210	4
2024-11-29	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,105	46.08	$143,078.40	42,246	4
2024-11-26	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	45.88	$142,228.00	42,246	4
2024-11-26	Maniar, Shweta	Director	-	Direct	Sale	3,782	45.88	$173,518.16	10,902	4
2024-11-18	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	45.04	$139,624.00	42,246	4
2024-11-13	Corley, Jesse Anderson	Director	-	Direct	Purchase	5,795	44.74	$259,268.30	38,438	4
2024-11-12	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	1,330	46.13	$61,352.90	42,246	4
2024-11-07	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	55.24	$171,244.00	42,246	4
2024-11-04	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	51.36	$159,216.00	42,246	4
2024-10-30	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,105	51.91	$161,180.55	42,246	4
2024-10-28	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	50.64	$156,984.00	42,246	4
2024-10-22	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	49.68	$154,008.00	42,246	4
2024-10-18	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,105	50.41	$156,523.05	42,246	4
2024-10-14	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	50.09	$155,279.00	42,246	4
2024-10-08	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	48.26	$149,606.00	42,246	4
2024-10-01	Thunen, Shelley B	Officer	See remarks	Direct	Sale	15,000	48.70	$730,500.00	30,443	4
2024-09-30	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	49.04	$152,024.00	42,246	4
2024-09-23	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	53.08	$164,548.00	42,246	4
2024-09-17	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	3,100	56.11	$173,941.00	42,246	4
2024-08-05	Goldshleger, Ilya	Officer	See remarks	Direct	Sale	9,000	39.22	$352,980.00	42,246	4
2024-07-01	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	10,000	58.94	$589,400.00	13,938	4
2024-06-14	Andrews, Julie	Director	-	Direct	Sale	15,625	58.18	$909,062.50	30,287	4
2024-05-17	Tammenoms, Bakker Juliet	Director	-	Direct	Purchase	5,000	61.09	$305,450.00	34,840	4
2024-05-03	Kurtz, Ronald M Md	Director,Officer	President & CEO	Indirect	Sale	40,000	60.15	$2,406,000.00	764,610	4
2024-05-01	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	10,000	52.86	$528,600.00	13,938	4
2024-04-01	Thunen, Shelley B	Officer	Chief Financial Officer	Indirect	Sale	20,000	50.33	$1,006,600.00	8,402	4
2024-03-01	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	10,000	56.12	$561,200.00	13,691	4
2024-02-16	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	10,000	55.50	$555,000.00	26,475	4
2024-02-14	Tammenoms, Bakker Juliet	Director	-	Direct	Purchase	4,000	51.29	$205,160.00	29,840	4
2024-02-09	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	10,365	50.75	$526,023.75	26,475	4
2024-02-06	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	15,875	47.47	$753,586.25	13,691	4
2024-02-01	Weinberg, Eric	Officer	Chief Commercial Officer	Indirect	Sale	10,000	50.00	$500,000.00	299,978	4
2024-02-01	Link, William J Phd	Director	-	Indirect	Sale	28,250	49.78	$1,406,285.00	24,248	4
2024-02-01	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	7,129	49.50	$352,885.50	26,475	4
2024-01-26	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	31,772	47.11	$1,496,778.92	6,791	4
2024-01-22	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	5,000	48.00	$240,000.00	26,475	4
2024-01-22	Weinberg, Eric	Officer	Chief Commercial Officer	Indirect	Sale	10,000	48.00	$480,000.00	309,978	4
2024-01-18	Maniar, Shweta	Director	-	Direct	Sale	6,399	45.72	$292,562.28	12,130	4
2024-01-09	Weinberg, Eric	Officer	Chief Commercial Officer	Indirect	Sale	10,000	46.00	$460,000.00	319,978	4
2024-01-09	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	5,000	47.00	$235,000.00	26,475	4
2024-01-08	Corley, Jesse Anderson	Director	-	Indirect	Sale	2,000	45.03	$90,060.00	11,625	4
2024-01-08	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	15,000	43.33	$649,950.00	26,475	4
2024-01-08	Maniar, Shweta	Director	-	Direct	Sale	6,418	45.00	$288,810.00	18,529	4
2024-01-08	Warner, Robert Keith	Director	-	Indirect	Sale	23,750	42.90	$1,018,875.00	0	4
2024-01-08	Kurtz, Ronald M Md	Director,Officer	President & CEO	Indirect	Sale	62,500	44.25	$2,765,625.00	804,610	4
2024-01-08	Weinberg, Eric	Officer	Chief Commercial Officer	Indirect	Sale	10,000	42.00	$420,000.00	329,978	4
2024-01-02	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	10,000	39.20	$392,000.00	2,291	4
2023-12-27	Kurtz, Ronald M Md	Director,Officer	President & CEO	Indirect	Sale	22,500	41.09	$924,525.00	867,110	4
2023-12-22	Weinberg, Eric	Officer	Chief Commercial Officer	Indirect	Sale	1,285	40.00	$51,400.00	339,978	4
2023-12-22	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	5,000	40.00	$200,000.00	26,475	4
2023-12-18	Goldshleger, Ilya	Officer	Chief Operating Officer	Direct	Sale	10,937	39.12	$427,855.44	26,475	4
2023-12-15	Weinberg, Eric	Officer	Chief Commercial Officer	Indirect	Sale	8,715	40.01	$348,687.15	341,263	4
2023-12-15	Thunen, Shelley B	Officer	Chief Financial Officer	Direct	Sale	20,000	39.35	$787,000.00	2,291	4
2023-12-14	Kurtz, Ronald M Md	Director,Officer	President & CEO	Indirect	Sale	40,000	39.70	$1,588,000.00	889,610	4
2023-12-14	Corley, Jesse Anderson	Director	-	Indirect	Sale	12,000	40.12	$481,440.00	13,625	4
2023-12-11	Warner, Robert Keith	Director	-	Indirect	Sale	5,498	35.08	$192,869.84	23,750	4
2023-11-29	Tammenoms, Bakker Juliet	Director	-	Indirect	Sale	349,245	29.77	$10,397,023.65	0	4
2023-11-15	Tammenoms, Bakker Juliet	Director	-	Indirect	Sale	400,000	27.20	$10,880,000.00	494,313	4
2023-09-11	Tammenoms, Bakker Juliet	Director	-	Direct	Sale	2,950	30.01	$88,529.50	20,223	4
2023-08-29	Maniar, Shweta	Director	-	Direct	Sale	4,292	28.06	$120,433.52	24,947	4
2023-08-25	Tammenoms, Bakker Juliet	Director	-	Direct	Sale	16,208	29.25	$474,084.00	53,173	4
2023-08-18	Tammenoms, Bakker Juliet	Director	-	Direct	Sale	14,651	29.07	$425,904.57	68,411	4
2023-02-10	Tammenoms, Bakker Juliet	Director	-	Indirect	Purchase	480,000	12.50	$6,000,000.00	980,000	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

87.52%

Inst. Shares: 36,149,987

Shares Outstanding: 41,306,110

2025-12-31

88.04%

Inst. Shares: 35,965,542

Shares Outstanding: 40,850,739

2025-09-30

79.94%

Inst. Shares: 32,749,363

Shares Outstanding: 40,965,219

2025-06-30

86.97%

Inst. Shares: 35,436,256

Shares Outstanding: 40,743,786

2025-03-31

84.39%

Inst. Shares: 34,185,002

Shares Outstanding: 40,509,646

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	36,149,987	41,306,110	87.52%
2025-12-31	35,965,542	40,850,739	88.04%
2025-09-30	32,749,363	40,965,219	79.94%
2025-06-30	35,436,256	40,743,786	86.97%
2025-03-31	34,185,002	40,509,646	84.39%
2024-12-31	33,625,857	38,867,726	86.51%
2024-09-30	31,904,875	39,788,621	80.19%
2024-06-30	30,498,495	38,455,955	79.31%
2024-03-31	27,438,376	36,843,087	74.47%
2023-12-31	25,881,579	34,455,111	75.12%
2023-09-30	22,866,549	35,662,397	64.12%
2023-06-30	19,988,637	34,498,265	57.94%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

RxSight, Inc. (RXST) — SEC Financial Statements & Analysis

RxSight, Inc. (RXST) is a ophthalmic goods company, incorporated in DE. RxSight, Inc. trades on Nasdaq as: RXST. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), RxSight, Inc. reported a -14.05% year-over-year revenue growth, a Gross Profit Margin of 77.02% (TTM), a Debt-to-Equity ratio of 0.14x, a Price-to-Sales (P/S) ratio of 2.00x (TTM), a Price-to-Book (P/B) ratio of 0.95 (TTM), at a market cap of $254.45M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -14.05%
Gross Profit Margin TTM: 77.02%
Debt To Equity: 0.14x
P/S TTM: 2.00x
P/B TTM: 0.95
Market Cap: $254.45M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RxSight, Inc. in?

RxSight, Inc. (RXST) operates in the Ophthalmic Goods industry.

What is RXST's market cap?

RxSight, Inc. (RXST) has a market capitalization of $254.45M as of 2026-03-31.

What exchange does RXST trade on?

RxSight, Inc. (RXST) trades on the Nasdaq.

Where is RxSight, Inc. incorporated?

RxSight, Inc. is incorporated in DE.

RxSight, Inc. (RXST) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.